Nucleic Acids in Chemistry and Biology

(Rick Simeone) #1

  1. E.S. Newlands, M.F.G. Stevens, S.R. Wedge, R.T. Wheelhouse and C. Brock, Temozolomide: a
    review of its discovery, chemical properties, pre-clinical development and clinical trials. Cancer
    Treat. Rev., 1997, 23 , 35–61.

  2. J. Arrowsmith, S.A. Jennings, A.S. Clark and M.F.G. Stevens, Antitumor imidazotetrazines. 41.
    Conjugation of the antitumor agents mitozolomide and temozolomide to peptides and lexitropsins
    bearing DNA major and minor groove-binding structural motifs. J. Med. Chem., 2002, 45 ,
    5458–5470.

  3. M. Tomasz, Mitomycin C: small, fast and deadly (but very selective). Chem. Biol., 1995, 2 , 575–599.

  4. L.H. Hurley and D.R. Needham-Vandevanter, Covalent binding of antitumour antibiotics in the
    minor groove of DNA, mechanism of action of CC1065 and the pyrrolo[1,4]benzodiazepines. Acc.
    Chem. Res., 1986, 19 , 230–237.

  5. G. Subramaniam, M.M. Paz, G.S. Kumar, A. Das, Y. Palom, C.C. Clement, D.J. Patel and
    M. Tomasz, Solution structure of a guanine-N7-linked complex of the mitomycin C metabolite
    2,7-diaminomitosene and DNA. Basis of sequence selectivity. Biochemistry, 2001, 40 , 10473–10484.

  6. R.W. Armstrong, M.E. Salvati and M. Nguyen, Novel interstrand crosslinks induced by the
    antitumour antibiotic carzinophilin/azinomycin B. J. Am. Chem. Soc., 1992, 114 , 3144–3145.

  7. R.S. Coleman, R.J. Perez, C.H. Burk and A. Navarro, Studies on the mechanism of action of
    azinomycin B: definition of regioselectivity and sequence selectivity of DNA cross-link formation
    and clarification of the role of the naphthoate. J. Am. Chem. Soc., 2002, 124 , 13008–13017.

  8. L.H. Hurley, T. Reck, D.E. Thurston, D.R. Langley, K.G. Holden, R.P. Hertzberg, J.R.E. Hoover,
    G. Gallagher, L.F. Faucette, S.M. Mong and R.K. Johnson, Pyrrolo[1,4]benzodiazepine antitumor
    antibiotics: relationship of DNA alkylation and sequence specificity to the biological activity of
    natural and synthetic compounds. Chem. Res. Toxicol., 1988, 1 , 258–268.

  9. W.A. Remers, M.D. Barkley and L. Hurley, Pyrrolo(1,4)benzodiazepines. Unraveling the complexity of
    the structures of the tomaymycin-DNA adducts in various sequences using fluorescence, proton-NMR,
    and molecular modeling. in Nucleic Acid Targeted Drug Design, C.L. Propst and T.J. Perun (eds) QC
    Marcel Dekker, New York, 1992, 375–422.

  10. M.L. Kopka, D.S. Goodsell, I. Baikalov, K. Grzeskowiak, D. Cascio and R.E. Dickerson, Crystal
    structure of a covalent DNA-drug adduct: anthramycin bound to C-C-A-A-C-G-T-T-G-G and a
    molecular explanation of specificity. Biochemistry, 1994, 33 , 13593–13610.

  11. U. Galm, M.H. Hager, S.G. Van Lanen, J. Ju, J.S. Thorson and B. Shen, Antitumor antibiotics:
    bleomycin, enediynes, and mitomycin. Chem. Rev., 2005, 105 , 739–758.

  12. A. Prokop, W. Wrasidlo, H. Lode, R. Herold, F. Lang, G. Henze, B. Doerken, T. Wieder and P.T.
    Daniel, Induction of apoptosis by enediyne antibiotic calicheamicin theta II proceeds through a
    caspase-mediated mitochondrial amplification loop in an entirely Bax-dependent manner.
    Oncogene, 2003, 22 , 9107–9120.

  13. D.L. Meyer and P.D. Senter, Recent advances in antibody drug conjugates for cancer therapy.
    Ann. Rep. Med. Chem., 2003, 38 , 229–237.

  14. M. Yus and F. Foubelo, Enediynes. Recent developments. Recent Res. Dev. Org. Chem., 2002, 6 ,
    205–280.

  15. I.H. Goldberg, Mechanism of neocarzinostatin action: role of DNA microstructure in determination
    of chemistry of bistranded oxidative damage. Acc. Chem. Res., 1991, 24 , 191–198.

  16. R.A. Kumar, N. Ikemoto and D.J. Patel, Solution structure of the calicheamicin gamma-1I-DNA
    complex. J. Mol. Biol., 1997, 265 , 187–201.

  17. K.C. Nicolaou, B.M. Smith, K. Ajito, H. Komatsu, L. Gomez-Paloma and Y. Tor, DNA-carbohydrate
    interactions. Specific binding of head-to-head and head-to-tail dimers of the calicheamicin
    oligosaccharide to duplex DNA. J. Am. Chem. Soc., 1996, 118 , 2303–2304.

  18. R.A. Kumar, N. Ikemoto and D.J. Patel, Solution structure of the esperamicin-A 1 -DNA complex.
    J. Mol. Biol., 1997, 265 , 173–186.

  19. L. Yu, S. Mah, T. Otani and P. Dedon, The benzoxazolinate of C-1027 confers intercalative DNA
    binding. J. Am. Chem. Soc., 1995, 117 , 8877–8878.


336 Chapter 8


http://www.ebook3000.com

Free download pdf